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We recently proposed that a  special category of idiotopes called regulatory 
idiotopes  play  an  important  role  in  idiotype-driven events  in  an  autologous 
system (1,  2).  Regulatory idiotopes are defined by three criteria: the ability to 
function as  autoimmunogens,  the  potential  to  become dominantly expressed 
because they are recognized by regulatory T  cells, and their shared expression 
by antibodies with different antigenic specificities (3). 
The regulatory idiotope concept originated from an immunochemical analysis 
of four members of an idiotypic network pathway initiated by ABPC-48 (A48), 
a monoclonal protein with/32-6 fructosan binding activity. By studying polyclonal 
populations of syngeneic Ab2 (anti-Id), Ab3 [anti(anti-Id)], and Ab4 (anti[anti(anti- 
Id)]) antibodies, we found that Ab3 antibodies share A48 idiotopes because Ab2 
and Ab4 bind to both A48 and Ab~ antibodies (1).  To explain these results, we 
proposed that Abl antibodies bear a special set of idiotopes which are immuno- 
genic in an autologous system and which elicit the production of Abe. Parenteral 
administration of these Ab2 antibodies would lead to the activation of Ab~ clones 
that express mainly these regulatory idiotopes.  Hence, the immunization with 
Ab3 antibodies would lead primarily to  the production of anti-regulatory idi- 
otope antibodies. 
This concept suggests that, through such an "idiotype cascade immunization," 
clones with the predicted idiotopes are activated. A corollary is that those clones 
activated by anti-Id antibodies will display the same antigen specificity as the Abl 
which initiated the cascade.  Furthermore, the idiotypes borne by such clones 
may be phenotypic markers of the same germline heavy chain variable region 
(VH) 1 gene from which is derived the VH genes encoding the specificity of these 
antibodies.  This  last characteristic represents an important trait that differen- 
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tiates  the  regulatory idiotopes  from  "conventional" idiotopes (as  described by 
Oudin)  that  result  from  noninheritable  somatic  recombination  or  mutational 
events. 
We have recently shown (4) that the A48-Id is shared by UPC-10 and other 
monoclonal antibodies,  some  of which  exhibit ~2-6  fructosan-binding activity 
while others, such as the MOPC-173  myeloma protein, do not.  The V. region 
expressed by A48 and UPC-10 derives from the Vu  44~4 germline gene (5), which 
belongs to the small X-24 V gene family (VH  441"4 and VH  x24) located at the 5' end 
of the Vu gene locus on chromosome 12 in the mouse (6). 
In this paper we demonstrate the existence of a hierarchy in the expression of 
idiotopes by a  panel of monoclonal antibodies.  Although  they derive from the 
same Vu germline gene, they exhibit various unexpected antigen-binding speci- 
ficities. 
Materials and Methods 
Animals.  New Zealand White rabbits of either sex, weighing 2 kg, were obtained from 
Pocono Farms, Canadensis, PA. 
Antigens.  Bacterial levan (BL) from Aerobacter levanicum  (ATCC1552) was obtained as 
previously described (1).  Grass (rye) levan (GL) was the kind gift of Dr. Franco Celada 
(Genoa University, Milan,  Italy). Insulin-bovine serum albumin (BSA) was coupled ac- 
cording to the method of Chien et al. (7). Galactan-BSA conjugate, arabinogalactan, and 
gum  ghatti  were  kindly donated  by  Dr.  M.  Potter (National  Cancer  Institute,  NIH, 
Bethesda, MD). 
Monoclonal  Antibodies.  (a) Monoclonal Abl and Ab3 antibodies: All antibodies used in 
this study have been previously described (4) and were purified by chromatography on 
Sephacryl G-300 (Pbarmacia, Inc., Uppsala,  Sweden) in  10 mM Tris-HCl, pH  8, 0.9% 
NaCI,  and 0.3% sodium azide. A  summary of their origins and isotype is presented in 
Table I. Ab~ antibodies of the AIDA series were kindly donated by Dr. Pierre Legrain 
(Pasteur Institute, Paris). 
(b)  Monoclonal anti-Idiotype antibodies:  IDA10, a  monoclonal, syngeneic (BALB/c) 
anti-Id antibody specific for A48 and UPC-10 was kindly donated by Dr. Pierre Legrain 
(Pasteur Institute), and is described in detail elsewhere (8). 10-1 is a monoclonal, semisyn- 
geneic anti-UPC-10-Id antibody obtained from a (BALB/c x  A/J)F1 mouse, as described 
(8).  Monoclonal rat anti-kappa chain antibody from the hybridoma 187.1  was the kind 
gift of Dr. M. Scharf (Albert Einstein College of Medicine, New York). 
Anti-V, lO Antibodies.  Purified light chains were prepared from partially reduced and 
alkylated UPC-10 antibodies according to the method ofJaton et al.  (9). The purity of 
the light chain preparation was assessed  by electrophoresis through a 5% sodium dodecyl 
sulfate  (SDS)-polyacrylamide gel  using  a  sodium  phosphate  buffer  system  (10).  The 
purified light chain protein was covalently coupled to keyhole limpet hemocyanin (KLH), 
after which this conjugate was  used to immunize rabbits as  previously described (11). 
Affinity-purified anti-VK  10 antibodies were prepared by elution from an UPC-10-Sepha- 
rose column and then adsorbed on other V, immunoadsorbents. The specificity of the 
eluted antibody was confirmed by radioimmunoassay (RIA) against a panel of monoclonal 
proteins expressing a variety of heavy chain isotypes and other VK subgroups. 
Immunochemical  Techniques.  (a) Determination of Id expression was carried out using 
a previously described, sensitive RIA sandwich technique (4) or an enzyme-linked immu- 
nosorbent assay (ELISA) inhibition assay. Briefly, for the RIA technique, microtiter plates 
were coated with  the  monoclonal test antibodies at  5  #g/ml  and then incubated with 
monoclonal anti-A48-Id or anti-UPC- 10-Id antibodies. After extensive washing the plates 
were incubated with 125Iqabeled A48 or UPC-10 protein, respectively. In the ELISA, the 
degree to which the test monoclonal antibodies inhibited the binding of alkaline phospha- 
tase-labeled monoclonal or polyclonal anti-A48-Id or anti-UPC-10-Id antibodies to A48 V1CTOR-KOBR1N  ET  AL.  649 
or UPC-10, respectively, was quantitated by incubating the alkaline phosphatase-labeled 
anti-Id antibodies,  first,  with  the  test  antibodies  (1  /~g/ml)  for  1 h  at  37°C,  and  then 
applying them to a  microtiter  plate previously coated with  A48 or UPC-10 (10/~g/ml) 
before  incubation  overnight at  4°C.  After  extensive  washing  with  phosphate-buffered 
saline  (PBS)-0.5%  Tween,  p-nitrophenylphosphate substrate  in  diethanolamine  buffer 
(0.4 mg/ml) was added to the plate. The reaction was allowed to develop at 37°C for 30 
min to 1 h before it was stopped by the addition of 25 ~1 of 3 N  NaOH to each well. The 
optical density at 405  nm was read on an ELISA microreader  (Dynatech Laboratories, 
Inc., Alexandria, VA). 
(b)  The antigen  binding specificity of the  monoclonal antibodies  was determined  in 
RIA by incubating  them  in  microtiter  plates  coated  with  GL,  BL, arabinogalactan,  or 
gum ghatti at 30 tLg/ml, and inulin-BSA or galactan-BSA conjugates at 3 gg/ml. Antibodies 
binding to these antigens were measured with 125I-rat anti-mouse C, (kappa chain constant 
region) monoclonal antibody (187. I) according to a previously described technique (4). 
(c)  Determination  of V,10 expression was carried out in an ELISA. Microtiter plates 
were coated with  10 #g/ml of affinity-purified monoclonal  187.1  anti-C,  or polyclonal 
rabbit anti-V,10 antibodies,  washed three  times with  PBS-0.5%  Tween,  and incubated 
overnight with alkaline phosphatase-labeled antibodies (1:5,000) as previously described 
(4).  The reaction was developed and quantitated as described above. 
Molecular Techniques.  (a)  Cytoplasmic RNA extraction: 5 X  10  7 tO  10  8 cells obtained 
from logarithmically growing cultures or ascitic fluid were washed twice in cold PBS and 
resuspended  in  3.0 ml of cold buffer containing 20 mM Tris-HCl,  2  mM CaC12, 3 mM 
MgCI2, pH 8.3. Cells were lysed by adding Nonidet P-40 to a final concentration of 1%, 
and the nuclei were immediately pelleted at  4°C.  To the supernatant,  in the following 
order, were added EDTA to a final concentration of 10 mM, NaCI to a final concentration 
of 0.1  M, and SDS to a final concentration of 0.5%.  This cytoplasmic lysate was phenol 
extracted  two  to  three  times,  followed by  the  same  number  of extractions  with  98% 
chloroform/2% isoamyl-alcohol. The RNA was then ethanol precipitated  and stored at 
-20°C. 
(b)  Oligo(dT) selection: Poly(A)  + mRNA was isolated after one cycle of selection over 
a  type  3  oligo(dT)-cellulose column  (Collaborative  Research  Inc.,  Lexington,  MA),  ac- 
cording to the method of Aviv and Leder (I 2). 
(c)  Genomic  DNA preparation:  5  X  107 to  l0 s cells  were washed  twice in  PBS and 
resuspended in 10 ml  10 mM Tris-HC1,  100 mM NaCI, 1 mM EDTA, pH 8 buffer. SDS 
was added to a final concentration of 0.5% to lyse the cells.  The lysate was digested with 
proteinase K at 200 #g/ml (EM Reagents, Federal Republic of Germany) for 3 h at 37 °C 
with constant rotation. The lysate was then phenol extracted three times, followed by an 
equivalent number of extractions with 98%  chloroform/2% isoamyl alcohol. The DNA 
was ethanol precipitated,  spooled out of the solution, and resuspended  in  10  mM Tris- 
HCI, 1 mM EDTA, pH 8, where it was stored at 4°C. 
(d)  32P-Nick-translation  of probes:  This  technique  was  carried  out  as  described  by 
Weinstock et al. (13). The presence of V,  4414 sequences was determined by hybridization 
Ga139  with  the  appropriate  enzyme fragment  of a  plasmid  containing the  V.  germline  V 
gene (kindly given to us by Dr. S. Rudikoff, NIH, Bethesda, MD), which has been shown 
to be identical in sequence to the V,  44~4 germline V  gene (25). The plasmid containing 
the  J606  V.  gene  kindly  given  to  us  by  Dr.  R.  Perlmutter,  California  Institute  of 
Technology, Pasadena, CA) was nick-translated in its entirety. 
(e)  Northern  blotting analysis: 200 ng of poly(A)  ÷ mRNA were resuspended  in  50% 
deionized formamide, 2.2 M formaldehyde, 20 mM 3-(4-morpholino)propanesulfonic acid 
(MOPS)/5 mM sodium acetate buffer, pH 7.0, and denatured by heating at 65°C for 10 
min. After quick chilling on ice for 5 min, Ficoll and bromphenol blue were added and 
the  RNA was fractionated  on a  0.8%  agarose gel containing 2.2  M  formaldehyde in a 
running  buffer  of 20  mM  MOPS,  5  mM  sodium  acetate,  1  mM  EDTA,  pH  7.  The 
electrophoresis was carried out in a wick-type apparatus at 4°C, 115 V, while continuously 
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was blotted onto BA85 nitrocellulose paper (Schleicher and Schuell,  Inc., Keene, NH) 
and hybridized as described by Thomas (15). 
(f)  RNA slot  blotting: Cytoplasmic RNA  was applied to BA85  nitrocellulose filters 
with a Minifold II apparatus (Schleicher and Schuell, Inc.) and hybridized to ~2P-labeled 
probes according to White et al, (16). 
(g)  Southern blotting: I 0 #g of genomic DNA were digested with 50 U Eco RI (New 
England Biolabs,  Beverly, MA) at 37°C for 3 h, and applied to a 40 mM Tris-HCl, 20 
mM acetate, 2 mM EDTA, 0.8% agarose gel, containing 1 #g/ml ethidium bromide. The 
DNA was transferred to BA85 nitrocellulose paper (17) and the blots were hybridized to 
32p-nick-translated  probes according to standard procedures (18). 
Results 
In  previous  studies  (19,  20),  we  showed  that  the  normally silent A48-Id  is 
expressed  by a  large proportion  of anti-BL antibodies in BALB/c mice immu- 
nized at birth with either the A48 monoclonal protein or anti-A48-Id antibodies. 
While the expansion of the A48-Id  + clones in the first system was mediated by 
ld-specific helper T  cells (19),  in  the  second  system it was  related  to a  direct 
expansion  of the  A48-Id  ÷ precursor  B  cells  (20).  Based  on  these  results,  we 
devised the following three protocols to generate the monoclonal antibodies used 
in this study. Series 1 antibodies were derived from BALB/c mice immunized at 
birth with A48 protein and challenged 1 mo later with BL. Series 2 antibodies 
are from BALB/c mice immunized at birth  with minute amounts of syngeneic 
anti-A48-Id antibodies and challenged  1 mo later with BL. Series 3 antibodies 
were obtained from adult BALB/c mice who were first hyperimmunized with an 
anti-A48-Id/KLH conjugate and then challenged with BL after completion of 
immunization. The monoclonal antibodies generated from each of these series 
were  screened  for their ability to inhibit the binding of 3H-A48  to polyclonal 
anti-A48-Id-coated  plates  (4).  Those  that  demonstrated  this  ability (Table  I) 
were selected for this study. The AIDA series are monoclonal antibodies obtained 
from  mice  immunized  with  IDA10  or  IDA23  monoclonal  anti-A48-Id/KLH 
conjugates  whose  antigen  specificity and  V,  origin  have  been  previously  de- 
scribed (21). 
Characterization  of the idiotypes Recognized by the Monoclonal Antiidiotopes  Used 
in this Study.  In our previous work (4), we observed that polyclonal anti-A48- 
Id  and  anti-UPC-10-Id  antibodies  recognized  antigen-inhibitable  as  well  as 
antigen-noninhibitable idiotypes (4).  Therefore,  it was important to determine 
the nature of the idiotope that was recognized by the two monoclonal antiidi- 
otopes,  IDA10 and  10-1,  used in this study. IDA10  is a  syngeneic anti-A48-Id 
antibody, and  10-1  is a  semisyngeneic anti-UPC-10-Id  antibody.  The  data in 
Fig.  1 show that  IDA10  recognizes antigen-inhibitable sites on  both  A48  and 
UPC-10.  10-1  recognizes an antigen-inhibitable idiotope on UPC-10 but not on 
A48,  because,  in  the  latter case,  50%  inhibition was achieved only at  1 ~g/ml 
BL, while the same degree of inhibition with UPC-10 was reached at <0.01  ~g/ 
nil. 
Characterization of the ldiotopes Displayed by the Monoclonal Antibodies.  An RIA 
was used to determine the reactivity of the monoclonal antibodies with IDA10 
and  10-1.  The  data  in  Table  II  show  that,  except  for  2-9-17,  all  monoclonal 
antibodies bound IDA-10.  However, the binding by the majority of the series  1 VICTOR-KOBRIN  ET  AL. 
TABLE  I 
Origin of Monoclonal Antibodies 
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Designation  Treatment of BALB/c donor mice 
ABPC-48, UPC-10, 
MOPC-173 
1-5-1 (U, ~) 
2-1-3  (3,3,  K) 
2-1-10  (3,3, ~) 
2-11-1  (U,~) 
2-11-3  (U, K) 
2-8-2  (#, x) 
2-28-9  (3"3,  ~) 
2-9-17  (/~, K) 
2-12-10 (tz, K) 
2-12-19 (u, ~) 
3-76-4  (#, K) 
3-76-42  (u, K) 
3-14-9  (U, K) 
3-27-6  (ul, K) 
3-101-14 (3,1, K) 
3-9-9  (U 1, ~) 
AIDA 10-16 (3,1, K) 
AIDA 10-21  (3,1, K) 
AIDA 23-2 (3,1, K) 
AIDA 23-3 (3,1, ~) 
BALB/c myeloma 
BALB/c mice injected at birth with  10 ug A48 and chal- 
lenged 1 mo later with 20/~g levan 
BALB/c mice injected at  birth  with  10  ng anti-A48-ld 
antibodies and challenged 1 mo later with 20/~g levan 
BALB/c mice hyperimmunized with polyclonal anti-A48- 
Id/KLH and challenged 1 mo later with 20/~g levan 
BALB/c mice immunized with IDA10-KLH conjugate 
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FIGURE  1.  Inhibition by BL of the binding of monoclonal anti-ld antibodies to the A48 and 
UPC-10 myeloma as determined in a solid phase RIA. Data points represent the mean of three 
measurements. Values of control (100%) cpm are: (O) 10-1 with A48,789; (A) 10-1 with UPC- 
10,  8,522; (O) IDAI0 with A48, 8,797; and (&) IDA10 with UPC-10,  17,711.  See Materials 
and Methods for experimental details. 652  REGULATORY  IDIOTOPES 
TABLE  II 




IDA10  10-1 
MOPC-460*  184 _+ 17'  51 +-- 13 
A48  5,183 + 289  456 -  20 
UPC-10  1,492 -- 141  2,213 + 278 
MOPC-173  519 -+ 233  681 + 212 
1-5-1  991 + 301  215 -  184 
2-1-3  679 + 228  319 +  128 
2-8-2  804 + 276  404 -  15 
2-11-1  728 ± 313  454 + 93 
2-12-10  1,140 +  136  532 + 288 
2-9-17  356 + 257  246 -_,2_ 43 
2-28-9  795 +  181  932 -  222 
3-76-4  1,548 _+ 128  217 +- 86 
3-14-9  3,745 +  152  554 +  175 
3-27-6  6,030 -+ 369  640 +  186 
3-9~9  3,078 -+ 111  349 -  144 
3-101-14  2,093 _+ 41  204 + 92 
AIDA 10-16  1,616 + 457  531 -  216 
AIDA 10-21  3,197 -  674  667 --- 148 
AIDA 23-2  9,619 _+ 107  747 _-4- 258 
AIDA 23-3  9,578 -+ 553  678 --+ 185 
IDAI0 is a syngeneic monoclonal anti-A48-Id antibody; 10-1 is a monoclonal  anti-UPC-10-1d 
antibody. In a different experiment, using another preparation of ~5I-A48 and ~SI-UPC-10 of 
different specific activity, we found that 2.1.10 bound IDA10, whereas 2-11-3, 2-12-19, and 3-76- 
42 bound both IDAI0 and 10-1. 
* MOPC-460 is an IgA, with dinitrophenyl  binding specificity. 
~" Average cpm -  S  E after the subtraction of background (3 % BSA instead of monoclonal  antibodies). 
and  2  antibodies was  lower  than  the  binding of A48,  UPC-10,  or  any of the 
series  3  antibodies. The  anti-UPC-10-Id  (10-1)  was  bound by several series  2 
antibodies, i.e., 2-1 1-3 and 2-12-19, as well as series 3 and AIDA antibodies (i.e., 
3-76-42, AIDA  10-21). 
Characterization  of V~lO Light Chain Expression.  The  differences observed in 
the magnitude of binding of monoclonal anti-Id antibodies IDA10 and  10-1  to 
the antibodies expressing A48 and UPC-10 idiotopes can be related to hetero- 
geneity in the  VH or VL regions.  From protein sequence data,  it is known that 
UPC-10  and  MOPC-173  use  a  V~10  light chain  (22).  Therefore,  it  appeared 
important  to  determine  whether  or  not  the  idiotopes  recognized  by  anti-Id 
antibodies required the association of the appropriate V. with a VK 10 light chain. 
In an ELISA, we studied the expression of V~10  light chain by several A48- 
I d +,  UPC-10-Id  + antibodies using an affinity-purified rabbit anti-V~l  0  antibody 
obtained from an anti-UPC-10 light chain serum.  Since the  various antibodies 
have  been  purified from  ascites  on  Sepharose  columns, their  binding to  anti- VICTOR-KOBR1N  ET  AL.  653 
TABLE  III 
Binding of Alkaline Phosphatase-labeled Monoclonal Antibodies to Rabbit 
Anti-V, lO Antibodies 
Labeled antibodies 
Microtiter plates coated with: 
BSA  Anti-r  Anti-V,l  0 
A48  0.08 ± 0.01"  0.84 _  0.02  0.29 --- 0.01 
UPC-10  0.18 ± 0.02  1.34 4- 0.03  0.91  -  0.05 
MOPC-173  0.10 ___ 0.01  1.44 + 0.01  0.96 ± 0.04 
PY211  0.10±0  0.62±0.01  0.09+0 
PY207  0.09 ± 0.01  0.66 ± 0.01  0.01  ± 0.01 
XY102  0.09 ± 0.01  1.06 ___ 0.03  0.10 ± 0.01 
1-5-1  0.19  0.62 ± 0.03  1.47 ± 0.06 
2-11-1  0.17 ± 0.02  1.47 ± 0.01  0.20 ± 0.02 
2-17-2  0.19 ± 0.04  1.23 + 0.04  0.46 ± 0.03 
3-9-9  0.19 ± 0.05  1.59 + 0.01  0.25 ± 0.03 
3-27-6  0.13 ± 0.01  0.94 ___ 0.16  0.42 ± 0.07 
3-101-14  0.22 ± 0.06  1.58 ± 0.01  0.34 ± 0.05 
AIDA 10-16  0.10 ± 0.02  0.49 ± 0.01  0.20 ± 0.01 
AIDA 10-21  0.10 ± 0.01  0.83 ___ 0.02  0.28 ± 0.0! 
AIDA 23-2  0.17 :!: 0.03  1.57 + 0.01  0.34 ± 0.05 
AIDA 23-3  0.10 ± 0.01  0.96 ± 0.01  0.10 ± 0.01 
PY211,  PY207,  and XY102 are monoclonal antibodies specific for influenza virus hemagglutinin 
using VK21 light chain. Background binding to microtiter plates coated with BSA varied between 
0.09 and 0.22 and was subtracted. 
* Optical density at 405 nm (mean of triplicate determinations _  SE). 
V~ 10 antibodies was compared  with a  monoclonal rat anti-mouse  C~ antibody at 
a  constant protein dilution. 
The  data  in  Table  III  show  that  three  influenza  virus-specific  antibodies 
known to use V~212 bound to only anti-C~ antibody, whereas UPC-10 and MOPC- 
173,  known  to  use  V~10  (22)  bound  well  to  both  the  anti-CK  and  anti-VA0 
reagents. The  monoclonal  1-5-1  exhibited a  higher binding to anti-V~l 0  than to 
anti-CK, whereas A48, 2-17-2, and 3-27-6 showed significant binding to anti-VK 10 
antibodies and a  much  stronger binding to the anti-C~ antibodies. 
RNA Slot Blotting Analysis of the Hybridomas.  Usage by the hybridomas of V. 
sequences  related to the 441-4  or J606  Vu genes,  which encode  the V.  regions 
of A48  and  J606,  respectively,  was  rapidly  surveyed  by  slot  blotting  various 
amounts  of  their  cytoplasmic  RNA  and  hybridizing  the  filters  with  32P-nick- 
translated  VH  441-4 or  VH  J606 probes.  RNA  from all the  hybridomas except 2-8-2, 
3-76-42,  and  3-76-4  hybridized  with  the  VH  441-4 probe.  Hybridization  with  the 
J606  Vu probe was obained only with J606  RNA  (data not shown). 
Northern Blotting Analysis of the Hybridomas.  To confirm that the hybridization 
observed  by  slot  blotting  was  due  to  full-length,  polyadenylated  heavy  chain 
mRNA  and  not  to  incomplete  immunoglobulin  transcripts often  seen  in  B  cell 
hybridomas, we performed  Northern  blotting experiments. 
Cytoplasmic poly(A)  + RNA  from each series 1, 2, 3, and AIDA  hybridoma was 
electrophoresed,  Northern  blotted,  and  the  filters  hybridized  under  highly 
2 Moran, T.  M., M.  Reale, J.  Schulman, M. Monestier, R.  Mayer, M. A. Thompson, R.  Riblet, 
and C.  A.  Bona.  Monoclonal antibodies that  define a  shared idiotope on antibodies to different 
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stringent conditions with the 32p-nick-translated  VH  441-4 probe. As shown in Figs. 
2 and 3, in all instances where we observed hybridization of a hybridoma's RNA 
in slot blotting, we observed, by Northern  blotting,  hybridization  of the VH  441"4 
probe.  The  size  of this  mRNA  species  is  consistent  with  the  isotype  of the 
antibody produced by the hybridoma.  RNA from  hybridomas not hybridizing 
with  this  probe,  namely,  series  2  antibodies  2-8-2,  2-11-3,  2-9-17,  and  2-12-9, 
and series 3 antibodies 3-76-4 and 3-76-42, was again slot blotted and hybridized 
to a # constant region probe to verify that this lack of VH  441"4 hybridization was 
not due to a lack of # mRNA in these IgM-producing hybridomas. Hybridization 
was observed in all cases except 3-76-4 and 3-76-42. These two hybridomas are 
currently being recloned. 
Southern  Blotting  Analysis.  The  molecular  configuration  of the  two  genes 
belonging to the X24 V. family, 441-4 and X24, were studied in those hybrids 
in which the H chain mRNA hybridized to the VH  441-4 probe. Genomic DNA was 
digested with Eco RI and Southern blotted. Duplicate blots were hybridized with 
the  VH  441"4 probe, as well as a J3-J4 probe, to confirm  the  identity  of the band 
representing rearranged  441-4 or X24 VH gene sequences. 
FIGURE 2.  Northern blotting analysis of series  1 and 2  hybridomas:  200  ng of oligo(d'Y)- 
selected  RNA  was  electrophoresed  through  a  0.8%  formaldehyde-containing agarose  gel, 
Northern blotted, and hybridized to the 32P-nick-translated VH  441"4 probe. 
FIGURE 3.  Northern blotting analyses of series 3 hybridomas: 200 ng of oligo(dT)-selected 
RNA was electrophoresed through a  0.8%  formaldehyde-containing agarose gel,  Northern 
blotted, and hybridized to a2P-nick-translated gl.i  441-4 probe. VICTOR-KOBRIN  ET  AL.  655 
As can be seen (Fig. 4A) in BALB/c liver, both unrearranged genes belonging 
to this family migrate as a single 500 basepair (bp) Eco RI fragment, which agrees 
with  previously published  observations  (6).  All  the  series  1  and  2  hybridomas 
show hybridization with  the  441-4  VH probe to the same  2.91  kb band,  which 
represents a  rearrangement of these  V  sequences to the J3-J4 cluster (Fig.  4, A 
and  B).  This  fragment  is  distinct  from  the  A48  rearrangement.  By  contrast, 
among the series  3  hybridomas,  we see five different types of rearrangements, 
including the one observed in  A48.  Bands of 2.95,  2.55,  2.4,  2.2, and  1.65  kb 
are seen, consistent with the usage of four different J, sequences (Fig.  5, A and 
B). 
Antigen Binding Spec~city of the Monoclonal Antibodies.  The antigen  binding 
specificities of monoclonal antibodies were examined in an RIA using GL (/32-6 
fructosan  linkages),  BL  (/32-6  and  /32-1  fructosan  linkages),  and  inulin  (/32-1 
fructosan  linkages)  (Table  IV).  As  previously reported (23),  A48  and  UPC-10 
bound to GL and  BL but not to inulin,  demonstrating  their specificity for the 
/32-6 fructosan linkage. On the other hand, J606 bound to BL and inulin but not 
to GL, indicating the specificity for the/32-1  fructosan linkage.  1-5-1, a  series  1 
antibody, bound only to BL. Of the  10 antibodies of series 2, 2 displayed the/32- 
6  fructosan-specific binding of A48,  4  bound only to BL, and  1 bound to BL 
and  inulin,  as  does  /32-1  fructosan-specific J606  protein.  Surprisingly,  three 
antibodies bound to all three polysaccbarides. 
However,  the  binding  of these  three  antibodies  to  BL  was  not  inhibited  by 
either inulin or GL (data now shown).  These data suggest that these antibodies 
have a very low affinity for isolated/32-6 or/32-1 fructosan linkages and recognize 
some conformational determinant present in the BL polysaccharide. 
Of the  10 antibodies of series 3 and the AIDA series, 4  had no demonstrable 
binding activity to any of the polysaccharides,  1 bound to all of them, and the 
FIGURE 4.  Southern blotting analysis of series 1 and 2 hybridomas: 10 tzg of Eco Rl-digested 
genomic DNA was electrophoresed through  a 0.7% agarose gel and Southern blotted. The 
filters were hybridized to a ~P-nick-translated VH  441~ (A) and J3-J4 probes (B), respectively. 
The 500 bp tragment containing the germline VH  441-4 and VH  x24 genes, respectively, was run 
off the gel on this blot but has been observed ill all these hybridomas in other blots. 656  REGULATORY  1D1OTOPES 
FIGURE 5.  Southern  blotting analysis of series  3  hybridomas:  10  ttg of Eco  RI-digested 
genomic DNA was electrophoresed through a  0.7%  agarose gel and Southern blotted. The 
filters were hybridized to a 32p-nick-translated VH  441"4 (A) or J3-J4 probe (B). The 3-10-4 lane 
was taken from another Southern blot carried out under identical conditions and aligned here 
according to fragment size computed by ~ Hind III marker migration. 
remaining 5  bound,  respectively, to  GL and inulin; GL only; BL only; inulin 
only; and to inulin only, with very low affinity. 
Galactan  Binding  Abilities of Antibodies  Lacking  Fructosan  Specificity.  The 
V.  Ga~'~' and Vl-I  TM  germline V genes are used to derive the active V. region gene 
encoding  the  fll-6-D-galactan-binding  properties  of myeloma proteins  (24). 
While V~  ~;'139 is identical with VH  441"4, VH X24 differs by seven substitutions from 
the 441-4 genes. The homology is great enough to suggest that these two genes 
may have arisen via a  gene duplicate process (25).  The extreme relatedness of 
these  two  V  genes  prompted  us  to  investigate whether or  not those series  3 
monoclonal antibodies that displayed the A48-Id but exhibited no specificity for 
fructosan determinants could, in fact, bind galactan determinants. An RIA was VICTOR-KOBRIN  ET  AL.  657 
TABLE  IV 
Antigen Binding Specificity of Monoclonal Antibodies 
Designation  Rye levan  Bacterial levan  Inulin 
MOPC-460  225 -  79*  376 -  116  44 -  2 
A48  5,659 +  275  12,819 -  945  91  -  5 
UPC-10  1,353 +  95  19,233 -  723  188 +  30 
MOPC-173  194 +  32  234-+ 45  67 +  21 
J606  360 --+ 87  4,265 +  833  5,875 -  419 
1-5-1  819 --. 272  12,576 -+  1,867  223 -  53 
2-1-3  4,013 -  328  12,570 -  903  8,347 -  1,024 
2-1-10  802 -  222  8,503 +  1,516  249 -  147 
2-8-2  1,057 +  161  16,232 -  1,418  98 +  47 
2-11-1  1,592 +  206  13,286 +  805  186 +  40 
2-11-3  102 --+ 3  12,354 +  697  151  +  26 
2-12-10  113 -+ 76  11,230 --.  1,650  40 -  13 
2-12-19  2,528 --. 408  15,028 _+  1,095  1,453 +  527 
2-9-17  62 -  15  13,434 +  2,915  2,228 --- 645 
2-28-9  666 -  294  5,232 +  1,421  61  -  21 
3-76-4  550 --- 69  127 ---  1  77 +  12 
3-76-42  1,544 +  352  190 -  41  1,171  +  271 
3-14-9  5,623 +  947  1,413 +  263  3,583 -  733 
3-27-6  1,693 -+ 293  96 -  11  177 -+ 88 
3-9-9  118 _  30  126 _+  14  105 -  19 
3-101-14  103 -  19  152 -  12  1,482 -  275 
AIDA 10-16  179 --+  119  2,888 --+ 291  125 --. 89 
AIDA 10-21  143 --- 76  294 ---  145  486 --+ 235 
AIDA 23-2  311  +  86  151  ---  125  149 -  34 
AIDA 23-3  164 -+ 44  405 +  127  851  -  180 
* Counts per minute _  SE of triplicate determinations. 
TABLE  V 
Binding to Galactan of Monoclonal Antibodies Devoid of[32,6 Fructosan Binding Activity 
Monoclonal antibodies  Arabinogalactan  Galactan-BSA 
Gum ghatti (20 ug/ml) 
(5 #g/ml)  (20 #g/ml)  (5 ug/ml) 
BSA  65+3*  86---  13  119+  18 
A48  299 -+  199  357 -  105  191  -  07 
XRPC-24  872 --+  13  5,272 ---  161  3,537 -  51 
MOPC-173  694 -+ 61  981  -4- 242  919 +  268 
3-9-9  273 +  45  183 -  21  189 -  15 
3-101-4  249 +  42  301  +  63  215 +  30 
AIDA 10-21  730 -  352  575 --- 64  465 -  107 
AIDA 23-2  1,709 -  324  1,832 -  300  1,376 -  54 
AIDA 23-3  296 -  112  709 -  110  483 -  96 
* Average cpm of triplicate determinations -  SE. 
used  to  examine  the  ability  of  five  such  monoclonal  antibodies  and  the  MOPC- 
173  myeloma  to  bind/31-6-D-galactan  determinants  found  in  galactan-BSA  and 
in  two  naturally  occurring  polysaccharides,  arabinogalactan  and  gum  ghatti. 
The  data  in  Table  V  show  that  the  monoclonal  AIDA  23-2  is specific  for/31- 658  REGULATORY  IDIOTOPES 
TABLE  VI 
Inhibition of Binding of Alkaline Phosphatase-labeled  Anti-A  48-Id and Anti-UPC-lO-Id 
Antibodies to A48 and UPC-IO by ~ l-6-D-Galactan-binding  Myeloma Proteins 
Inhibitors (1  ug/ml) 
Idiotypic systems 
Anti-A48*/A48  Anti-UPC-10*/UPC-10  IDA10*/A48 
Nil  0.84 -+ 0.03*  1.26 -- 0.02  1.38 --- 0.03 
A48  0.10 --- 0.01  1.14 --- 0.04  0.03 --- 0.01 
UPC-10  0.80 -+ 0.02  0.10 --- 0.01  0.91  -+ 0.04 
XRPC-24  1.08 +  0.01  1.28 --- 0.03  1.38 -+ 0.03 
XRPC-44  0.96 +  0.02  0.63 +  0.03  1.31  +  0.03 
TEPC-601  1.01  -+ 0.03  1.23 -+ 0.03  1.29 -- 0.03 
J539  1.02 +  0.06  1.02 --!- 0.01  1.32 --- 0.02 
*  Labeled antibody. 
$ OD405; average of triplicate determinations  -  SE. 
6-D-galactans  since  it  bound  to  all  the  galactan  polysaccharides  in  this  RIA. 
AIDA  10-21,  AIDA  23-2,  and  the  MOPC-173  myeloma  exhibited  a  lower 
galactan-binding activity but were clearly above background values. 
Because  the  ability  of A48-Id-bearing  antibodies  to  bind  galactan  was  so 
unexpected,  we decided to investigate whether galactan-binding  myeloma pro- 
teins express A48 and  UPC-10 idiotopes. This was examined by studying in an 
ELISA  the  ability  of four  galactan-binding  myeloma  proteins  to  inhibit  the 
binding of either  polyclonal or monoclonal  anti-Id  antibodies to A48 or UPC- 
10.  The  galactan-binding  myeloma protein  XRPC44 inhibited  by 50%  (Table 
VI) the binding of syngeneic polyclonal anti-UPC-10-Id antibodies to UPC-10. 
The  results  clearly  demonstrate  that  one  of four  galactan-binding  myeloma 
proteins shares an idiotope with UPC-10. 
Discussion 
The data in this paper demonstrate  that  low doses of antiidiotypic antibodies 
can expand B cell precursors bearing the corresponding Id. Consistent with our 
earlier observations (19, 20), anti-Id antibodies administered to neonatal or adult 
mice  preferentially  expanded  Abl  or  Abl-like  clones,  rather  than  a  true  Ab~ 
population. The syngeneic origin of the antiidiotypic antibodies makes it highly 
likely that  these  clones  were activated  through  regulatory  idiotopes.  Analysis 
with seven monoclonal anti-A48-Id  and two anti-UPC-10-Id antibodies identi- 
fied  two  monoclonals,  IDA10  (anti-A48-Id)  and  10-1  (anti-UPC-10-Id)  that 
recognize determinants  on most of the antibodies secreted by our hybridomas. 
The differences in  the binding  of the  IDA10 and  10-1  to various monoclonal 
antibodies appeared to be independent of Vk 10 light chain utilization.  However, 
our data do not preclude the possibility that these antibodies use VK 10 subgroups 
related to the UPC-10 VK10 light chain.  In the case of VK21, several subgroups 
have been identified (14) that are probably markers of active VK genes originating 
from six VK21 germline genes composing the VK21 germline gene family. Thus, 
our data suggest that A48 and UPC-10 regulatory idiotopes are mainly markers 
of VH regions.  Furthermore,  the  idiotopes recognized  by IDA10  and  UPC-10 
may not be identical to the one displayed by A48, due to a degree of heteroge- VICTOR-KOBRIN  ET  AL.  659 
neity in V, region itself. The series 3 antibodies bound to IDA 10 and 10-1 better 
than  did  those  from  series  1 and  2.  Whether  this  reflects  greater  homology 
between  VH  441-4  and  series  3  VH  sequences  will  be  determined  by nucleotide 
sequence analysis currently in progress. 
The  existence  of regulatory  idiotopes  on  antibodies  produced  by  cells  ex- 
panded  by anti-Id  had  suggested  that  such  idiotopes were V.  germline  gene 
markers. Our data strongly support this idea. Poly(A)+-enriched H chain mRNA 
from  most  of the  hybridomas  that  were  derived  from  clones  stimulated  with 
anti-A48-Id  antibodies,  hybridized to the  VH  441"4 probe under  highly  stringent 
conditions.  Furthermore,  we  demonstrated  in  Southern  blotting  experiments 
that  the  hybridomas  containing  mRNA  hybridizing  to  VH  441-4 also  had  DNA 
sequences hybridizing with the VH  44~-4 probe, rearranged  to the JH (heavy chain 
joining segment) cluster. This analysis further supports the notion that VH genes 
derived from the VH  441-4 germline gene code for Id-positive heavy chains. 
Interesting  molecular  differences  exist  between  hybridomas  derived  from 
clones expanded in neonatal vs. adult animals. While the 441-4 probe hybridized 
to  only  6  of  10  H  chain  mRNAs  from  series  1  and  2  hybridomas,  these  6 
hybridomas in Southern  blots all  demonstrated  the same rearrangement  to the 
J~ cluster of sequences complementary to the VH  441"4 probe. This rearrangement 
was different from that seen in A48 DNA. By contrast, H chain mRNA from all 
the series 3 hybridomas hybridized to the VH  441"4 probe, but the Southern blots 
revealed four patterns of rearrangement,  which may reflect random rearrange- 
ment of VH  441"4 complementary sequences to only one of the four JH sequences. 
Nucleotide sequence analysis of cDNA complementary to the VH region of the 
antibodies should provide further information on this point. 
Collectively,  these  results  show  that  regulatory  idiotopes  are  probably  V, 
germline  gene markers and that the majority of antibodies produced by clones 
activated by anti-ld antibodies are encoded by V~ genes deriving from a common 
V, germline gene. 
A  key prediction  of the regulatory idiotope concept is that clones exhibiting 
different antigenic specificities can be coordinately activated by virtue of shared 
regulatory idiotopes (2). The diverse antigen binding patterns manifested by our 
hybridomas are in complete agreement with this prediction.  All the hybridomas 
derived from newborn mice treated at birth with minute amounts of anti-A48- 
Id antibodies showed an affinity for a fructosan determinant that, in most cases, 
was different from the/32-6 linkage specifcity of A48 and UPC-10. Furthermore, 
several of these clones represent  a  new  type of fructosan-specific antibody,  as 
they display a  specificity for a  conformational  determinant  within the BL poly- 
saccharide that has never been observed among the numerous fructosan-binding 
myelomas studied  by  Lieberman  et  al.  (23).  In  contrast,  among  the  series  3 
antibodies  derived  from  adult  mice  treated  with  anti-A48-Id  antibodies,  only 
about half displayed an affinity for a fructosan determinant,  which again was not 
the A48 or UPC-10 specificity. Of the remaining  series 3 hybridomas, several, 
in addition,  surprisingly,  to the MOPC-173 myeloma, showed a clear specificity 
for the  /31-6-D-galactan  determinant.  The  significance  of this  observation  was 
reinforced  by finding  expression  of an  UPC-10  idiotope  on  one  of the  four 
galactan-binding myeloma proteins studied, i.e., XRPC44. Only one of the series 660  REGULATORY  IDIOTOPES 
3  hybridomas,  3-9-9,  which  did  not  show any affinity for either galactan  or 
fructosan determinants,  can  be  considered a  true  anti(anti-A48-Id)  antibody 
(i.e., Ab3). 
If the A48 regulatory idiotope is a  marker of the VH  441°4 gene, one may ask 
how we can explain the diverse array of antigen specificities among these A48 
regulatory idiotope-bearing hybridomas. The expression of this same germline 
V gene in the context of different D (diversity) and J. segments, or of different 
light  chains,  might  subtly alter  the combining site  such  that,  although  these 
antibodies still recognize fructosan determinants, their precise specificity differs 
from that of A48 and UPC-10.  The finding of antibodies binding the antigen- 
ically  unrelated  galactan  determinant  was  not  completely unexpected,  since 
VH  441-4 is identical to the VH  ~al39 germline gene and differs by only 7 bp from VH 
X24 (25). This finding does, however, emphasize a major point of the regulatory 
idiotope concept.  Anti-Id antibodies  will  certainly activate clones bearing idi- 
otope, but, if the regulatory idiotope is a germline V gene marker, clones with 
various antigen specificities may be activated through a crossreactive regulation 
process. 
We define "cross-regulation" as a humoral and cellular mechanism controlling 
discrete sets of clones via recognition of self-regulatory idiotopes. This concept 
emphasizes that  there is a  major difference between the expression of clones 
expanded via  recognition of foreign antigen and the clonal proliferation that 
occurs after recognition of self idiotope. 
Antigenic stimulation should invoke a low degree of cross-regulation since the 
activated clones have a  very restricted antigenic specificity and can express a 
multitude  of idiotopes  depending  on  the  number  of distinct  epitopes.  The 
activation of clones induced by anti-Id would be Id restricted but would exhibit 
a broader spectrum of specificities. This spectrum is probably limited to a group 
of antigens reacting with antibodies encoded by the active V genes of a  single 
V.  gene  family.  Cross-regulation  also  implies  a,competition  between  clones, 
leading to  the dominance of those that  express  regulatory idiotopes and  the 
suppression of other clones. Our data strongly support this idea since we observed 
that  A48-Id and  UPC-10-1d,  minor idiotopes of a  conventional anti-levan re- 
sponse, became dominant idiotypes in animals receiving minute amounts of Id- 
bearing or anti-Id antibodies either parenterally at birth or in utero by crossing 
the placenta (26).  The ability to expand clones with various antigen specificities 
by anti-Id antibodies, particularly in ontogeny, demonstrates that cross-regulation 
mediated by the recognition of self-regulatory idiotypes can shape the immune 
repertoire. This also shows that the equilibrium established between clones in 
the  immune system,  which  is  based  on  idiotypic  links,  is  weak,  since  minute 
amounts of Id or anti-Id could upset it and lead to the clonal dominance of a 
minor Id. 
Summary 
Hybridomas secreting antibodies bearing the ABPC48  (A48) regulatory idi- 
otype (Id) were generated from BALB/c mice treated at birth or as adults with 
minute  amounts  of anti-A48-Id  antibodies.  The  majority of these antibodies 
were recognized by the syngeneic monoclonal anti-A48-Id and anti-UPC-10-Id VICTOR-KOBRIN  ET  AL.  661 
antibodies,  IDA10  and  10-1,  respectively.  In  Northern  blotting  experiments, 
most of these hybridomas were shown  to use VH (heavy chain  variable region) 
genes related to the 441-4  germline VH gene that encodes the A48  VH region. 
Hybridization  was  detected  between  polyadenylated H  chain  mRNA,  isolated 
from  the  majority  of the  hybridomas,  and  the  VH  441"4 probe.  Southern  blots 
confirmed these results by showing a rearrangement of VH4414-related sequences 
to  the JH  (H  chain joining  segment)  clusters  on  these  same  hybridomas.  The 
antibodies from all of the hybridomas that derived from neonatal mice and half 
of those derived from adult mice showed specificity for fructosan determinants 
that, in most cases,  was different from the/32-6 fructosan linkage specificity of 
A48.  Surprisingly,  several of the non-fructosan-binding hybridomas generated 
from the adult mice and the MOPC-173 myeioma demonstrated a clear specificity 
for the/31-6-D-galactan determinant. Of four galactan-binding myeloma proteins 
studied,  XRPC  44  alone  shared  idiotypy  with  the  UPC-10  myeloma.  These 
findings suggest a possible clonal crossreactive regulation mediated by regulatory 
idiotopes. The crossreactive regulation concept is discussed. 
Received for publication  10 April 1985. 
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